Journal article icon

Journal article

Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trial.

Abstract:

OBJECTIVE: To determine whether the immunogenicity of a single dose infant priming schedule of serogroup C meningococcal (MenC) conjugate vaccine is non-inferior to a two dose priming schedule when followed by a booster dose at age 12 months. DESIGN: Phase IV open label randomised controlled trial carried out from July 2010 until August 2013 SETTING: Four centres in the United Kingdom and one centre in Malta. PARTICIPANTS: Healthy infants aged 6-12 weeks followed up until age 24 months. INTER...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Publisher's version

Actions


Access Document


Files:
Publisher copy:
10.1136/bmj.h1554

Authors


Expand authors...
National Institute for Health Research More from this funder
GlaxoSmithKline Biologicals More from this funder
European Society of Paediatric Infectious Diseases More from this funder
Publisher:
BMJ Publishing Group Publisher's website
Journal:
BMJ (Clinical research ed.) Journal website
Volume:
350
Issue:
apr01 16
Pages:
h1554-h1554
Chapter number:
ARTN h1554
Publication date:
2015-01-01
DOI:
EISSN:
1756-1833
ISSN:
0959-8138
URN:
uuid:31f566e6-0d0c-4b34-b6cf-f519fb994ecf
Source identifiers:
516909
Local pid:
pubs:516909

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP